HBS Enterprises, LLC – Trademark Portfolio

Entity Type: 16

HBS Enterprises, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BEST IN SHOW PET TREATS. The owner is based in Louisville, KY.

P.O. Box 6748

Louisville, KY 40206

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HBS Enterprises, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

31
Natural Agricultural Products (2 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does HBS Enterprises, LLC have?

HBS Enterprises, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does HBS Enterprises, LLC file in?

HBS Enterprises, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 31 (Natural Agricultural Products). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are HBS Enterprises, LLC's most well-known trademarks?

HBS Enterprises, LLC's registered trademark portfolio includes well-known marks such as BEST IN SHOW PET TREATS. These are among 1 currently registered trademark in the portfolio.

What is HBS Enterprises, LLC's trademark registration success rate?

HBS Enterprises, LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.